Regulation of Growth Hormone-Independent Insulin Like Growth Factor-Binding Protein (BP-28) in Cultured Human Fetal Liver Explants*

Publisher Website
Google Scholar
Abstract
Cultured human fetal liver explants were used to study regulation of the GH-independent insulin-like growth factor-binding protein (BP-28). BP-28 was produced by fetal liver explants at approximately 200 ng/mg total tissue protein .cntdot. day between days 3 and 6 in culture and was inhibited 60% after 3-day exposure to cycloheximide (10 .mu.g/mL). BP-28 production was stimulated over 3-fold by 20 mmol/L theophylline, over 2-fold by 30 .mu.mol/L forskolin, and 90% by 10 .mu.g/mL glucagon. The glucose concentration in the medium inversely regulated BP-28 production, which was 68% higher in 2 mmol/L glucose than in 30 mmol/L glucose (P < 0.001); in contrast, albumin production was 40% lower in 2 mmol/L glucose than in 30 mmol/L (P < 0.05). BP-28 levels were inhibited 50% by 300 nmol/L insulin or 3 .mu.mol/L dexamethasone. In acid extracts of cultured tissue, BP-28 levels were less than 10% of the amount secreted in 48 h. These results are consistent with the conclusion that intracellular glucose availability is an important regulator of hepatic BP-28 synthesis.

This publication has 32 references indexed in Scilit: